Journal of Clinical Respiratory Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Clinical Respiratory Medicine 44 7897 074717

Opinion Article - Journal of Clinical Respiratory Medicine (2025) Volume 9, Issue 1

Asthma Pathophysiology and Management: A Clinical Overview

Naftali Kaminski *

Critical Care and Sleep Medicine, Yale University, USA

*Corresponding Author:
Naftali Kaminski
Critical Care and Sleep Medicine, Yale University, USA
E-mail: naftali.kaminski@yale.edu

Received: 1-Mar-2025, Manuscript No. aajcrm-25-167780; Editor assigned: 4-Mar-2025, PreQC No. aajcrm-25-167780 (PQ) Reviewed:17-Mar-2025, QC No. aajcrm-25-167780Revised:24-Mar-2025, Manuscript No. aajcrm-25-167780; Published:31-Mar-2025, DOI: 10.35841/ aajcrm - 9.1.248

Citation: Kaminski N. Asthma pathophysiology and management: A clinical overview. J Clin Resp Med. 2025;9(1):248

Visit for more related articles at Journal of Clinical Respiratory Medicine

Introduction

Asthma is a chronic inflammatory disorder of the airways that affects over 300 million people globally. Characterized by episodes of wheezing, breathlessness, chest tightness, and coughing, asthma results from complex interactions between genetic predisposition and environmental triggers [1].

Understanding its pathophysiology is critical for effective clinical management and improving patient outcomes. The underlying mechanism of asthma involves airway inflammation, bronchial hyperresponsiveness and reversible airflow obstruction [2].

Inflammatory cells such as eosinophils, mast cells, and T-helper 2 lymphocytes infiltrate the airway walls, releasing cytokines and chemokines that perpetuate the inflammatory cycle. This leads to edema, increased mucus production, and smooth muscle hypertrophy, narrowing the bronchial lumen [3].

Airway remodeling can occur over time, contributing to persistent symptoms and reduced lung function. Environmental allergens (e.g., pollen, dust mites), respiratory infections, exercise, cold air, and irritants like smoke can trigger or exacerbate symptoms [4].

Genetic factors also play a role, influencing immune system behavior and airway reactivity. Effective asthma management is aimed at controlling symptoms, reducing exacerbations, and maintaining normal lung function [5].

Conclusion

Asthma remains a significant public health concern due to its chronic nature and potential for severe exacerbations. A thorough understanding of its pathophysiology enables targeted interventions to reduce inflammation and prevent airway remodeling. Personalized management, including pharmacological treatment and lifestyle modifications, is essential to achieving optimal control and enhancing the quality of life for asthma patients.

References

  1. Bhatiaa M, Chaudharya J, Jaina A, et al. Pathophysiology and management of asthma. Contemp Adv Sci Technol. 2022;4:17-42.

    2. Google Scholar

  2. Bush A. Pathophysiological mechanisms of asthma. Front Pediatr. 2019;7:68.

    3. Indexed at, Google Scholar, Cross Ref

  3. Bereda G. Bronchial asthma: Etiology, pathophysiology, diagnosis and management. Austin J Pulm Respir Med. 2022;9(1):1085.

    4. Indexed at, Google Scholar, Cross Ref

  4. Witt A, Douglass JA, Harun NS. Overview of recent advancements in asthma management. Intern Med J. 2022;52(9):1478-87.

    5. Indexed at, Google Scholar, Cross Ref

  5. Garg R, Piplani M, Singh Y, et al. Epidemiology, pathophysiology, and pharmacological status of asthma. Curr Respir Med Rev. 2022;18(4):247-58.

    6. Indexed at, Google Scholar, Cross Ref

Get the App